G M Campo - JoVE Visualize

Showing results (51-60 of 96) with videos related to

Pageof 10

Sort By:

Journal of Lipid Mediators and Cell Signalling|March 1, 1994

Evidence for a role of platelet activating factor in hypovolemic shock in the ratB Zingarelli, F Squadrito, F Bussolino, et al.

Circulatory Shock|July 1, 1992

Passive immunization with antibodies against tumor necrosis factor (TNF-alpha) protects from the lethality of splanchnic artery occlusion shockF Squadrito, D Altavilla, M Ioculano, et al.

Research Communications in Chemical Pathology and Pharmacology|June 1, 1992

IRFI-016, a new radical scavenger, limits ischemic damage following coronary artery occlusion in ratsG M Campo, F Squadrito, M Ioculano, et al.

Pharmacology|December 1, 1994

Beneficial effects of BAY u3405, a novel thromboxane A2 receptor antagonist, in splanchnic artery occlusion shockP Canale, F Squadrito, D Altavilla, et al.

The Journal of Pharmacology and Experimental Therapeutics|April 1, 1996

Protection of ischemic and reperfused rat myocardium by the nonglucocorticoid 21-aminosteroid U-74389G, a new inhibitor of lipid peroxidationG M Campo, F Squadrito, D Altavilla, et al.

Pharmacological Research|July 1, 1995

Effects of gallopamil on epinephrine and norepinephrine plasmatic levels and on TxB2 and beta-tg release in patients with coronary artery disease during adrenergic stimulus with cold pressor testA Saitta, M Bonaiuto, A Mileto, et al.

Angiology|November 20, 1998

Effects of picotamide on release of endothelin-1, thromboxane and prostacycline after treadmill stress in patients with peripheral artery diseaseA Saitta, A Sardo, M Bonaiuto, et al.

European Journal of Pharmacology|November 3, 1995

G 619, a dual thromboxane synthase inhibitor and thromboxane A2 receptor antagonist, inhibits tumor necrosis factor-alpha biosynthesisD Altavilla, F Squadrito, P Canale, et al.

British Journal of Pharmacology|December 1, 1994

Participation of tumour necrosis factor and nitric oxide in the mediation of vascular dysfunction in splanchnic artery occlusion shockF Squadrito, D Altavilla, P Canale, et al.

European Journal of Pharmacology|April 16, 1999

The lazaroid, U-74389G, inhibits inducible nitric oxide synthase activity, reverses vascular failure and protects against endotoxin shockD Altavilla, F Squadrito, G M Campo, et al.

Pageof 10

Showing results (51-60 of 96) with videos related to

Sort By:

Pageof 10

Journal of Lipid Mediators and Cell Signalling|March 1, 1994

Evidence for a role of platelet activating factor in hypovolemic shock in the ratB Zingarelli, F Squadrito, F Bussolino, et al.

Circulatory Shock|July 1, 1992

Passive immunization with antibodies against tumor necrosis factor (TNF-alpha) protects from the lethality of splanchnic artery occlusion shockF Squadrito, D Altavilla, M Ioculano, et al.

Research Communications in Chemical Pathology and Pharmacology|June 1, 1992

IRFI-016, a new radical scavenger, limits ischemic damage following coronary artery occlusion in ratsG M Campo, F Squadrito, M Ioculano, et al.

Pharmacology|December 1, 1994

Beneficial effects of BAY u3405, a novel thromboxane A2 receptor antagonist, in splanchnic artery occlusion shockP Canale, F Squadrito, D Altavilla, et al.

The Journal of Pharmacology and Experimental Therapeutics|April 1, 1996

Protection of ischemic and reperfused rat myocardium by the nonglucocorticoid 21-aminosteroid U-74389G, a new inhibitor of lipid peroxidationG M Campo, F Squadrito, D Altavilla, et al.

Pharmacological Research|July 1, 1995

Effects of gallopamil on epinephrine and norepinephrine plasmatic levels and on TxB2 and beta-tg release in patients with coronary artery disease during adrenergic stimulus with cold pressor testA Saitta, M Bonaiuto, A Mileto, et al.

Angiology|November 20, 1998

Effects of picotamide on release of endothelin-1, thromboxane and prostacycline after treadmill stress in patients with peripheral artery diseaseA Saitta, A Sardo, M Bonaiuto, et al.

European Journal of Pharmacology|November 3, 1995

G 619, a dual thromboxane synthase inhibitor and thromboxane A2 receptor antagonist, inhibits tumor necrosis factor-alpha biosynthesisD Altavilla, F Squadrito, P Canale, et al.

British Journal of Pharmacology|December 1, 1994

Participation of tumour necrosis factor and nitric oxide in the mediation of vascular dysfunction in splanchnic artery occlusion shockF Squadrito, D Altavilla, P Canale, et al.

European Journal of Pharmacology|April 16, 1999

The lazaroid, U-74389G, inhibits inducible nitric oxide synthase activity, reverses vascular failure and protects against endotoxin shockD Altavilla, F Squadrito, G M Campo, et al.

Pageof 10